Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.

Artivion, Inc.

Balton CP provides timely and technologically advanced solutions in agribusiness, technology, and electromechanical services primarily for African farmers and businesses. Self-described as a forerunner in technology and rooted in agribusiness.

Balton CP

BIOTRONIK is a private, global medical device company that develops products and services to save lives and improve the quality of life for patients with cardiovascular and endovascular diseases. The company has been focusing on patient care for over 50 years.

BIOTRONIK

Endospan develops and manufactures custom-made endovascular devices for aortic arch treatment, including the NEXUS Aortic Arch Stent Graft System and NEXUS DUO Aortic Arch Stent Graft.

Endospan

Artivion develops technologies and solutions focused on treating patients with diseases of the aorta, particularly aimed at cardiac and vascular surgeons' challenges, self-described as advancing aortic technologies.

Metric
Company Name	Artivion, Inc.	Balton CP	BIOTRONIK	Endospan
Symbol	AORT
MSH ID	COM:ARTIVION	COM:BALTONCP	COM:BIOTRONIK	COM:ENDOSPAN
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Consumer Goods	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Devices	Agriculture and Technology	Medical Devices	Medical Devices
Country	US	KE	NL	IL
Stage				Debt Financing
Employee Count	1.50K
Website	artivion.com	baltoncp.com	biotronik.com	endospan.com
LinkedIn				endospan
Founders

Metric
Market Cap	1.09B
Enterprise Value
Monthly Web Traffic		293
Web Traffic Growth		-0.25
Valuation
Raised Capital		25M

Metric
Revenue	354.00M
Revenue (LTM)
Revenue (NTM)
Gross Profit	213.98M
EBITDA	37.86M
Operating Income	14.79M
Net Income	-30.57M
EPS	-0.75
Diluted EPS	-0.75
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.65
Operating Profit Margin	0.09
EBITDA Margin	0.11
Net Profit Margin	-0.02
Return on Equity	-0.03
Return on Assets	-0.01
Return on Capital Employed	0.05

COM:ARTIVION

Artivion

Last Close

28.03

22/11 21:00

Market Cap

1.09B

Beta: -

Volume Today

222.37K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-27.81
P/B Ratio	2.51
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.18
EV Multiple	138.13

Metric
Days Sales Outstanding	73.35
Days Payables Outstanding	32.70
Days Inventory Outstanding	239.70
Operating Cycle	316.14
Cash Conversion Cycle	277.20
Asset Turnover	0.48

Metric
Operating Cash Flow	18.58M
Free Cash Flow	11.15M
Cash Flow to Debt	0.06
Operating Cash Flow/Sales	0.05
Free Cash Flow Yield	-0.00

Metric
Cash & Equivalents	58.94M
Accounts Receivable	-4.05M
Inventory	81.98M
Goodwill	247.34M
Debt to Capitalization	0.55
Debt to Assets	0.46
Current Ratio	4.86
Quick Ratio	3.16

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.04
R&D to Revenue	0.09
SG&A to Revenue